The FDA Approved a New Drug to Treat Alzheimer's, but Medicare Won't Always Pay for It The Conversation - April 14, 2022 Andrew Williams, M.D., writes about Medicare's coverage restrictions on the new Alzheimer's disease drug Aduhelm and explores the drug's mixed results in clinical trials. Dr. Williams is assistant professor of emergency medicine at Einstein and an emergency medicine physician at Montefiore.